complaint
relat
upper
airway
arguabl
one
common
reason
present
commun
pharmaci
primari
care
provid
contribut
substanti
loss
product
absenc
work
school
deckx
et
al
sclar
et
al
common
cold
influenza
allergi
affect
larg
proport
popul
everi
year
infect
upper
respiratori
tract
urti
show
season
trend
case
peak
winter
month
allergi
may
either
season
perenni
depend
allergen
sensit
necessari
elicit
suffici
histori
patient
reach
differenti
diagnosi
manag
symptom
appropri
respiratori
tract
serv
vital
function
bring
oxygen
bodi
distribut
throughout
bodi
via
vascular
system
expel
toxic
carbon
dioxid
respiratori
tract
divid
two
section
upper
lower
respiratori
tract
upper
airway
also
refer
upper
respiratori
tract
consist
nose
nasal
passag
paranas
sinus
pharynx
throat
larynx
voic
box
lower
airway
consist
trachea
bronchi
lung
purpos
upper
airway
take
filter
humidifi
air
well
expel
carbon
dioxid
respir
common
cold
common
cold
common
infect
upper
respiratori
tract
common
cold
caus
viru
strain
predominantli
rhinovirus
also
human
coronavirus
adenovirus
heikkinen
et
al
success
vaccin
common
cold
yet
develop
heikkinen
common
cold
primarili
affect
nose
pharynx
sinus
present
symptom
often
includ
block
runni
nose
fever
headach
cough
sore
throat
sneez
common
cold
transmit
air
droplet
infect
individu
breath
commonli
enter
bodi
eye
mouth
via
hand
come
contact
contamin
surfac
arrol
keneali
unlik
influenza
antivir
therapi
avail
erad
caus
viru
jefferson
tyrrel
common
cold
usual
mild
selflimit
natur
averag
durat
day
arrol
keneali
viru
penetr
tissu
airway
result
local
inflamm
present
nasal
discharg
sneez
sore
throat
cough
children
experi
cold
year
adult
infect
year
infect
may
sever
young
elderli
immunocompromis
arrol
keneali
unlik
common
cold
influenza
colloqui
refer
flu
seriou
infect
tend
present
abrupt
onset
symptom
may
includ
system
symptom
restrict
upper
airway
lethargi
diarrhea
nausea
muscular
ach
number
strain
influenza
viru
known
infect
human
broadli
divid
type
type
b
type
c
influenza
influenza
viru
transmit
similarli
common
cold
via
air
droplet
infect
individu
radojic
individu
often
say
experienc
influenza
present
common
cold
import
pharmacist
differenti
two
educ
patient
differ
although
season
influenza
infect
may
prove
fatal
young
elderli
immunocompromis
epidem
strain
recent
swine
flu
strain
also
potenti
kill
otherwis
fit
healthi
individu
donaldson
et
al
unlik
common
cold
influenza
treat
antivir
therapi
neuraminidas
inhibitor
oseltamivir
zanamivir
stop
viru
replic
jefferson
et
al
season
attenu
live
influenza
vaccin
produc
annual
recommend
routin
vaccin
certain
popul
immunocompromis
pregnant
women
radojic
pharmacist
may
abl
administ
vaccin
certain
jurisdict
worthi
note
vaccin
produc
use
chicken
egg
peopl
known
allergi
egg
receiv
vaccin
radojic
pharmacolog
manag
upper
respiratori
tract
infect
commun
pharmaci
consist
primarili
symptomat
relief
present
symptom
choic
product
base
patient
prefer
present
symptom
clinic
consider
contraind
potenti
drugdrug
interact
patient
present
upper
respiratori
tract
infect
cough
classifi
product
chesti
nonproduct
dri
nonproduct
cough
may
result
increas
throat
irrit
due
sensit
viru
wherea
product
cough
result
increas
mucos
secret
fuller
jackson
opioid
deriv
commonli
sold
cough
suppress
antituss
suppress
cough
reflux
medulla
brain
stem
provid
relief
frequent
cough
common
drug
includ
dextromethorphan
pholcodin
dihydrocodein
codein
may
sold
syrup
medic
lozeng
tablet
capsul
limit
qualiti
evid
benefit
agent
smith
et
al
howev
consum
demand
product
may
high
caution
taken
prepar
may
caus
drowsi
codein
dihydrocodein
dextromethorphan
implic
serotonin
toxic
given
patient
take
drug
known
contribut
serotonin
toxic
patient
present
nonproduct
cough
known
asthma
suppli
cough
suppress
may
contribut
respiratori
depress
mask
sign
symptom
asthma
flareup
narcot
cough
suppress
may
subject
misus
abus
must
consid
suppli
order
combat
misus
abus
formul
contain
lax
sorbitol
discourag
consumpt
supratherapeut
dose
product
cough
present
cough
mucu
expector
cough
drug
licens
manag
product
cough
fall
two
categori
expector
protuss
mucolyt
like
antituss
drug
come
syrup
medic
lozeng
tablet
capsul
expector
guaifenesin
stimul
secret
mucu
airway
reduc
adhes
improv
efficaci
cough
clear
mucu
mucolyt
exampl
bromhexin
act
thin
mucu
facilit
easier
clearanc
mucolyt
expector
sometim
sold
combin
product
provid
synergist
effect
aid
cough
manag
similar
antituss
qualiti
evid
clinic
efficaci
expector
mucolyt
limit
rubin
smith
et
al
unit
state
food
drug
administr
advis
cold
flu
product
avoid
children
year
age
due
risk
seriou
advers
effect
follow
announc
manufactur
unit
state
chang
packag
cold
flu
product
state
use
children
year
age
fashner
et
al
u
food
drug
administr
respons
withdraw
market
product
contain
complementari
medicin
ivi
leaf
hedera
helix
enter
market
treatment
option
children
although
individu
studi
suggest
efficaci
prepar
qualiti
data
random
control
trial
lack
holzing
chenot
nonmed
altern
cough
syrup
demulc
simpl
syrup
honey
ingredi
includ
mani
cough
syrup
thought
respons
report
symptom
relief
use
syrup
propos
may
increas
saliv
secret
pulmonari
mucu
eccl
fuller
jackson
safe
use
children
popul
medic
syrup
lozeng
contraind
sore
throat
manifest
infect
common
cold
influenza
due
increas
inflamm
throat
sore
throat
may
either
viral
bacteri
natur
vast
major
case
caus
viru
sore
throat
attribut
bacteri
infect
often
caus
streptococcu
pyogen
result
term
strep
throat
pustul
throat
tonsil
necessarili
indic
bacteri
infect
caus
organ
sore
throat
determin
cultur
throat
swab
consid
associ
symptom
sore
throat
lozeng
gargl
spray
may
contain
combin
antiinflammatori
agent
flurbiprofen
benzydamin
hydrochlorid
antisept
agent
dichlorobenzyl
alcohol
local
anesthet
lidocain
povidoneiodin
throat
gargl
also
use
notion
use
gargl
reduc
viral
load
throat
satomura
et
al
povidoneiodin
shown
exert
antibacteri
antifung
antivir
activ
addit
throatspecif
product
patient
experienc
sore
throat
may
also
benefit
simpl
analgesia
acetaminophen
paracetamol
ibuprofen
regular
dose
simpl
analgesia
shown
improv
sore
throat
symptom
patient
schachtel
et
al
pain
fever
common
symptom
infect
common
cold
influenza
bodi
immun
system
respond
invad
viru
simpl
analges
acetaminophen
paracetamol
ibuprofen
also
exert
antipyret
effect
use
manag
pain
fever
nonsteroid
antiinflammatori
drug
nsaid
shown
effect
improv
pain
symptom
associ
common
cold
kim
et
al
aspirin
use
children
increas
risk
rey
syndrom
caution
may
requir
use
ibuprofen
nsaid
patient
asthma
hypertens
electrolyt
disturb
renal
impair
fever
children
particular
concern
parent
may
manag
overaggress
crocetti
et
al
pharmacist
role
educ
parent
fever
reduc
fever
phobia
routin
monitor
bodi
temperatur
necessari
uncompl
case
upper
respiratori
tract
infect
mucou
product
increas
nose
sinu
caviti
patient
may
experi
block
nose
result
difficulti
breath
nose
discomfort
patient
may
also
describ
thick
purul
discharg
nose
sympathomimet
commonli
use
block
nose
may
system
oral
topic
nasal
spray
drop
sympathomimet
use
prepar
includ
pseudoephedrin
phenylephrin
oxymetazolin
although
qualiti
evid
avail
poor
decongest
may
improv
subject
measur
symptom
insuffici
evid
suggest
whether
system
topic
agent
provid
superior
relief
deckx
et
al
topic
prepar
sympathomimet
use
threetof
consecut
day
due
risk
rebound
congest
rhiniti
medicamentosa
seem
occur
oral
decongest
topic
decongest
prefer
pregnanc
peopl
poorli
control
hypertens
due
low
level
system
exposur
sympathomimet
includ
topic
avoid
patient
use
monoamin
oxidas
inhibitor
eg
moclobemid
phenelzin
due
risk
hypertens
crisi
system
sympathomimet
use
children
year
age
wherea
topic
agent
appropri
year
jurisdict
sale
pseudoephedrin
may
control
prohibit
due
use
precursor
methamphetamin
leav
phenylephrin
remain
system
option
efficaci
oral
phenylephrin
compar
placebo
oral
pseudoephedrin
question
eccl
addit
medic
nasal
spray
salin
douch
drop
spray
may
also
use
clear
mucu
block
nose
salin
prepar
present
viabl
option
patient
use
sympathomimet
limit
evid
suggest
salin
irrig
may
help
reliev
symptom
associ
urti
although
may
clinic
signific
king
et
al
rhinorrhea
may
occur
upper
respiratori
tract
infect
result
allerg
rhiniti
allergi
case
rhinorrhea
result
upper
respiratori
tract
infect
symptomat
manag
achiev
muscarin
antagonist
atropin
nasal
spray
formul
albalawi
et
al
antihistamin
h
antagonist
monotherapi
sedat
less
sedat
appear
limit
effect
rhinorrhea
infecti
origin
symptom
common
cold
sutter
et
al
current
insuffici
qualiti
evid
use
intranas
corticosteroid
reliev
symptom
associ
common
cold
hayward
et
al
manag
allerg
rhinorrhea
see
section
allerg
rhiniti
gastrointestin
syptom
diarrhea
vomit
may
present
patient
infect
influenza
particular
pediatr
patient
dilantika
et
al
mainstay
therapi
patient
experienc
diarrhea
andor
vomit
ensur
adequ
hydrat
achiev
use
oral
rehydr
solut
avail
number
brand
formul
worldwid
oral
rehydr
solut
replac
essenti
electrolyt
lost
diarrhea
vomit
glucos
aid
sodium
absorpt
citrat
counter
acidosi
result
dehydr
revis
reducedosmalar
formula
contain
mmoll
glucos
sodium
mmoll
potassium
mmoll
chlorid
mmoll
citrat
prepar
may
sold
powder
effervesc
tablet
requir
reconstitut
clean
water
readytodrink
formul
patient
discourag
reconstitut
oral
rehydr
solut
use
rehydr
caffein
drink
soft
drink
soda
milk
fruit
juic
opioid
antidiarrh
agent
loperamid
diphenoxyl
often
suppli
combin
atropin
reduc
abus
potenti
avail
jurisdict
may
consid
adult
patient
combin
rehydr
therapi
shortterm
manag
symptom
social
conveni
jurisdict
antivir
medicin
may
avail
pharmacist
certain
circumst
without
prescript
physician
two
main
class
antivir
medicin
avail
manag
infect
influenza
neuraminidas
inhibitor
ion
channel
inhibitor
pharmacist
follow
local
guidelin
suppli
medicin
regard
time
sinc
onset
symptom
season
suppli
restrict
review
evid
state
poor
qualiti
trial
barrier
evalu
role
agent
prophylaxi
treatment
season
pandem
influenza
jefferson
et
al
howev
one
review
state
use
ion
channel
inhibitor
influenza
infect
discourag
jefferson
et
al
patient
demand
antibiot
upper
respiratori
tract
infect
may
high
may
driven
patient
belief
antibiot
help
get
better
faster
prevent
more
seriou
ill
experienc
common
cold
gualano
et
al
current
evid
suggest
antibiot
benefit
manag
common
cold
place
user
risk
advers
effect
keneali
arrol
patient
remind
antibiot
play
role
manag
common
cold
influenza
caus
organ
viral
bacteri
natur
product
contain
variou
combin
activ
ingredi
avail
market
combin
may
includ
ingredi
manag
one
symptom
analgesia
decongest
combin
product
may
conveni
patient
may
also
contain
subtherapeut
dose
irrat
combin
antituss
expector
may
increas
risk
duplic
therapi
evid
suggest
combin
product
effect
conveni
patient
inher
danger
singl
ingredi
prepar
eccl
et
al
pharmacist
ensur
patient
awar
ingredi
combin
product
ingredi
manag
symptom
present
use
complementari
medicin
may
often
sought
consum
upper
respiratori
tract
infect
either
reduc
symptom
sever
decreas
durat
symptom
prepar
may
commonli
includ
ingredi
vitamin
c
ascorb
acid
zinc
garlic
propoli
echinacea
ivi
leaf
hedera
helix
andrographi
paniculata
fashner
et
al
evid
support
use
prepar
mix
qualiti
individu
patient
circumst
potenti
advers
effect
drug
interact
patient
expect
must
consid
complementari
medicin
use
common
cold
precaut
must
taken
certain
patient
group
common
complementari
prepar
exampl
use
echinacea
patient
asthma
andrographi
pregnant
women
cochran
review
use
regular
vitamin
c
prevent
treatment
common
cold
suggest
mix
evid
regard
efficaci
prevent
may
role
undertak
extrem
exercis
place
cold
stress
efficaci
demonstr
reduc
durat
cold
symptom
howev
current
evid
suffici
recommend
routin
supplement
chalker
given
limit
risk
advers
effect
use
vitamin
c
low
cost
patient
may
wish
trial
vitamin
c
supplement
similarli
vitamin
c
evid
suggest
zinc
particular
zinc
lozeng
may
benefici
reduc
durat
cold
symptom
taken
close
onset
symptom
within
h
although
use
zinc
prophylaxi
establish
singh
da
echinacea
anoth
complementari
medicin
commonli
market
tablet
lozeng
claim
benefit
prevent
treat
common
cold
recent
cochran
review
examin
effect
echinacea
unabl
establish
recommend
base
includ
trial
although
acknowledg
prepar
may
benefit
although
clinic
signific
question
lk
et
al
patient
present
common
cold
often
told
rest
drink
plenti
fluid
increas
fluid
intak
recommend
notion
dehydr
may
occur
episod
upper
respiratori
tract
infect
may
also
assist
reduc
viscos
mucu
review
articl
unabl
establish
benefit
advic
primari
care
set
due
major
studi
observ
natur
inpati
set
guppi
et
al
addit
rest
increas
fluid
intak
steam
inhal
also
commonli
recommend
patient
upper
respiratori
tract
infect
believ
inhal
heat
humidifi
air
help
reliev
congest
associ
common
cold
also
hypothes
increas
temperatur
may
limit
abil
rhinovirus
replic
current
evid
demonstr
signific
benefit
harm
use
steam
inhal
except
nasal
irrit
lightheaded
worsen
congest
symptom
singh
et
al
topic
prepar
contain
camphor
menthol
eucalyptu
oil
vapor
rub
use
adult
children
alik
allevi
common
cold
symptom
commonli
appli
chest
area
upper
lip
recent
random
trial
compar
effect
vapor
rub
white
petroleum
jelli
treatment
parent
percept
child
symptom
found
vapor
rub
superior
petroleum
jelli
treatment
although
irrit
report
use
vapor
rub
paul
et
al
pharmacist
commun
set
abl
reach
diagnosi
common
cold
rel
eas
event
clear
diagnosi
reach
seriou
infect
suspect
exampl
influenza
involv
lower
airway
patient
refer
medic
practition
assess
referr
also
warrant
event
prolong
recurr
symptom
especi
cough
infect
result
exacerb
chronic
respiratori
condit
asthma
chronic
obstruct
pulmonari
diseas
suspect
dehydr
highgrad
fever
neck
stiff
young
infant
elderli
cough
persist
greater
week
concomit
breath
difficulti
wheez
pain
inspir
blood
sputum
persist
nocturn
cough
particularli
children
also
requir
referr
allergi
affect
nose
allerg
rhiniti
common
among
popul
estim
approxim
european
popul
world
popul
experi
allerg
rhiniti
bauchau
durham
allerg
rhiniti
character
inflamm
nasal
passag
congest
itch
sneez
rhinorrhea
symptom
result
inflammatori
chemic
mediat
releas
histamin
leukotrien
prostaglandin
due
activ
immunoglobulin
type
e
ige
surfac
mast
cell
nasal
passag
respons
presenc
trigger
allergen
immun
respons
tend
result
sneez
bilater
wateri
rhinorrhea
first
may
progress
nasal
congest
addit
nasal
symptom
ocular
symptom
may
also
present
initi
activ
immun
respons
extra
inflammatori
cell
eosinophil
tlymphocyt
attract
site
result
chronic
inflamm
presenc
cell
also
result
prime
immun
respons
result
increas
sensit
offend
allergen
well
allergen
greiner
formal
diagnosi
common
patient
often
correctli
selfdiagnos
selfmanag
symptom
allerg
rhiniti
classifi
sever
way
includ
whether
season
perenni
intermitt
persist
mild
moderatesever
name
suggest
season
allerg
rhiniti
hay
fever
trigger
season
allergen
high
pollen
count
spring
presenc
allergen
implic
season
rhiniti
durat
presenc
allergen
differ
depend
time
year
geograph
locat
unlik
season
allerg
rhiniti
experi
perenni
allerg
rhiniti
may
experi
symptom
time
expos
allergen
anim
dander
dust
mite
mold
spore
although
individu
experienc
allerg
rhiniti
symptom
high
degre
presente
work
school
product
may
reduc
symptom
present
qualiti
life
impact
econom
burden
allerg
rhiniti
estim
billion
dollar
year
unit
state
alon
crystalpet
et
al
individu
may
present
pharmaci
symptom
attribut
common
cold
may
fact
experienc
allergi
reach
differenti
diagnosi
pharmacist
consid
associ
symptom
timelin
symptom
recent
social
histori
person
famili
medic
histori
unlik
upper
respiratori
tract
infect
fever
headach
cough
thick
nasal
discharg
cough
common
allerg
rhiniti
symptom
bilater
natur
ie
nostril
affect
case
symptom
unilater
requir
referr
investig
symptom
suggest
allerg
rhiniti
may
worthwhil
take
recent
social
histori
identifi
possibl
trigger
identifi
exampl
patient
may
expos
friend
cat
moldi
room
person
famili
medic
histori
may
assist
confirm
differenti
diagnosi
person
famili
histori
atopi
allerg
rhiniti
asthma
andor
atop
dermat
atop
triad
often
present
patient
asthma
may
comorbid
allerg
rhiniti
poorli
control
allerg
rhiniti
comorbid
asthma
result
poorer
asthma
control
increas
asthma
medic
use
manag
symptom
specif
offend
allergen
identif
caus
allergen
necessari
commenc
therapi
treatment
aim
reduc
sever
symptom
subsequ
impact
qualiti
life
case
reduc
likelihood
futur
flare
up
complic
number
prepar
manag
allerg
rhiniti
symptom
avail
overthecount
prescript
class
medicin
use
prepar
includ
h
antihistamin
oral
intranas
intranas
corticosteroid
inc
mast
cell
stabil
anticholinerg
agent
decongest
oral
intranas
intranas
leukotrien
receptor
antagonist
choic
treatment
base
frequenc
sever
symptom
patient
prefer
includ
cost
treatment
region
variat
guidelin
manag
allerg
rhiniti
must
consid
make
therapeut
recommend
intranas
corticosteroid
consid
firstlin
therapi
patient
moder
sever
allerg
rhiniti
effect
control
symptom
result
inflammatori
respons
inc
exert
effect
decreas
releas
cytokin
chemic
implic
inflammatori
mechan
allerg
rhiniti
cell
nasal
mucosa
exert
immunosuppress
effect
via
glucocorticoid
receptor
mani
agent
avail
market
includ
budesonid
fluticason
mometason
shown
effect
manag
allerg
rhiniti
patient
prefer
term
devic
dose
frequenc
cost
must
consid
order
choos
suppli
inc
patient
counsel
correct
use
devic
ensur
therapi
success
patient
also
inform
benefit
seen
within
h
howev
take
day
full
benefit
treatment
seen
patient
may
wish
use
oral
topic
antihistamin
initi
inc
therapi
due
faster
onset
effect
although
allerg
rhiniti
impact
asthma
aria
guidelin
state
limit
evid
support
need
routin
recommend
oral
antihistamin
conjunct
inc
bro
zek
et
al
conveni
use
inc
intranas
antihistamin
combin
product
avail
much
like
use
inhal
corticosteroid
asthma
advers
effect
typic
associ
system
corticosteroid
eg
adren
suppress
unlik
use
inc
advers
effect
restrict
local
irrit
nose
throat
h
antihistamin
act
block
action
receptor
therebi
reduc
inflammatori
effect
receptor
antihistamin
categor
either
sedat
first
gener
lesssed
second
gener
sedat
antihistamin
includ
promethazin
dexchlorpheniramin
exampl
oral
lesssed
antihistamin
cetirizin
like
caus
sedat
fexofenadin
loratadin
oral
antihistamin
may
prefer
patient
due
eas
use
cost
may
particularli
use
patient
nasal
ocular
symptom
due
system
effect
system
use
antihistamin
particular
sedat
antihistamin
may
result
undesir
advers
effect
sedat
dri
mouth
constip
evid
suggest
either
sedat
lesssed
antihistamin
efficaci
addit
oral
prepar
intranas
antihistamin
azelastin
also
avail
without
inc
intranas
antihistamin
shown
least
effect
oral
antihistamin
work
faster
may
prefer
patient
combin
therapi
intranas
antihistamin
inc
may
benefit
inc
alon
howev
aria
guidelin
place
emphasi
inc
prefer
choic
therapi
antihistamin
alon
bro
zek
et
al
leukotrien
receptor
antagonist
monteleukast
block
effect
leukotrien
leukotrien
receptor
thu
reduc
nasal
inflamm
subsequ
nasal
congest
leukotrien
receptor
antagonist
avail
physician
prescript
mani
jurisdict
agent
may
expens
antihistamin
limit
evid
suggest
use
antihistamin
howev
evid
suggest
may
use
patient
comorbid
asthma
bro
zek
et
al
much
like
manag
cold
symptom
decongest
either
topic
oral
may
use
allerg
rhiniti
allevi
congest
symptom
medicin
effect
inflammatori
respons
simpli
constrict
blood
vessel
reduc
mucu
product
may
use
monotherapi
manag
allerg
rhiniti
market
oral
decongest
may
sold
combin
antihistamin
topic
agent
eg
oxymetazolin
phenylephrin
use
extend
period
due
risk
rhiniti
medicamentosa
rebound
congest
advers
effect
system
agent
pseudoephedrin
includ
tachycardia
insomnia
reduc
appetit
sale
pseudoephedrin
restrict
market
due
use
precursor
methamphetamin
much
like
decongest
anticholinerg
ipratropium
may
use
allerg
rhiniti
common
cold
allevi
rhinorrhea
reduc
mucu
secret
nasal
passag
effect
underli
inflammatori
process
implic
allerg
rhiniti
may
littl
use
monotherapi
mast
cell
stabil
sodium
cromoglyc
avail
intranas
prepar
reduc
secret
inflammatori
mediat
histamin
mast
cell
nasal
mucosa
thu
reduc
inflamm
intranas
prepar
gener
welltoler
advers
effect
restrict
local
irrit
sodium
cromoglyc
less
efficaci
inc
may
prefer
option
possibl
peopl
experi
allerg
rhiniti
attempt
avoid
allergen
known
trigger
allergi
although
caus
allergen
may
alway
known
case
pollen
window
kept
shut
outdoor
time
restrict
particularli
pollen
count
high
cloth
bed
dri
cloth
dryer
rather
outdoor
wash
line
air
filter
either
insid
home
air
condit
unit
may
also
prove
use
instanc
allerg
rhiniti
mold
spore
dust
mite
regular
clean
may
help
reduc
exposur
allergen
case
physician
may
decid
patient
candid
skin
prick
allergi
test
effort
determin
allergen
may
respons
allerg
rhiniti
salin
irrig
nasal
douch
wash
anoth
practic
sometim
recommend
patient
allerg
rhiniti
achiev
use
either
isoton
sodium
chlorid
hypoton
hyperton
salin
prepar
administ
nose
sinu
caviti
either
spray
squeez
bottl
similar
devic
propos
mechan
action
procedur
mechan
flush
mucu
allergen
inflammatori
mediat
recent
cochran
review
found
limit
qualiti
evid
investig
use
salin
irrig
allerg
rhiniti
may
role
manag
head
et
al
given
favor
advers
effect
profil
uncommonli
local
irrit
feel
ear
full
nose
bleed
low
cost
treatment
salin
irrig
may
consid
manag
allerg
rhiniti
allerg
conjunct
allergi
affect
conjunctiva
eye
character
red
itchi
eye
wateri
discharg
estim
approxim
american
popul
experi
allerg
conjunct
lifetim
allerg
rhiniti
allerg
conjunct
result
igemedi
allergi
respons
presenc
allergen
eye
allerg
conjunct
may
classifi
season
occur
particular
time
year
accord
pollen
count
exampl
perenni
occur
time
year
respons
allergen
dust
mite
mold
anim
dander
allerg
conjunct
highli
comorbid
allerg
rhiniti
person
famili
histori
atopi
atop
dermat
asthma
andor
allerg
rhiniti
confirm
historytak
tabl
outlin
distinguish
characterist
three
primari
classif
conjunct
individu
red
eye
symptom
may
come
commun
pharmaci
seek
advic
treatment
may
misdiagnos
infecti
bacteri
conjunct
pharmacist
abl
reach
differenti
diagnosi
rel
eas
adequ
historytak
presenc
itch
key
differenti
factor
diagnosi
allerg
conjunct
along
person
famili
histori
atopi
wateri
discharg
may
present
viral
conjunct
dri
eye
syndrom
presenc
itch
consider
associ
symptom
help
distinguish
allerg
conjunct
condit
manag
bacteri
viral
conjunct
dri
eye
syndrom
cover
elsewher
book
goal
manag
conjunct
reduc
sever
symptom
case
reduc
chanc
reoccurr
eye
drop
recommend
part
therapi
patient
remind
correct
eyedrop
administr
techniqu
import
hygien
use
eye
drop
appropri
discard
date
open
dropper
bottl
suppli
singl
dose
unit
singledos
unit
preservativefre
prepar
may
prefer
known
sensit
commonli
use
preserv
benzalkonium
chlorid
user
contact
lens
advis
remov
lens
administr
eye
drop
replac
earlier
min
administr
oral
topic
antihistamin
may
consid
use
patient
present
allerg
conjunct
oral
antihistamin
may
prefer
patient
also
experienc
nasal
symptom
nasal
ocular
symptom
manag
oral
antihistamin
particular
sedat
antihistamin
promethazin
may
contribut
dri
eye
henc
lesssed
antihistamin
recommend
agent
topic
antihistamin
includ
levocabastin
ketotifen
pheniramin
administ
eye
drop
local
deliveri
result
faster
onset
action
oral
agent
advers
effect
topic
antihistamin
limit
local
irrit
eye
bad
tast
recent
review
found
topic
antihistamin
benefici
control
sign
symptom
allerg
conjunct
shortterm
use
unabl
make
recommend
avail
agent
castillo
et
al
mast
cell
stabil
includ
nedocromil
sodium
sodium
cromogl
sold
eye
drop
prepar
manag
allerg
conjunct
advers
effect
mild
limit
eye
nose
recent
review
found
mast
cell
stabil
may
use
control
sign
symptom
ocular
allergi
could
make
recommend
avail
agent
castillo
et
al
ocular
decongest
exampl
naphazolin
avail
singleingredi
eye
drop
combin
prepar
topic
antihistamin
role
allerg
conjunct
limit
superfici
reduct
red
eye
effect
underli
patholog
allerg
respons
topic
agent
use
nasal
congest
extend
use
ocular
decongest
may
result
conjunct
medicamentosa
rebound
hyperemia
patient
advis
avoid
use
prepar
extend
period
time
due
risk
system
absorpt
poor
administr
techniqu
caution
taken
recommend
ocular
decongest
patient
group
would
exclud
take
oral
decongest
eg
uncontrol
hypertens
concomit
use
phenelzin
well
risk
angleclosur
glaucoma
lubric
eye
drop
artifici
tear
normal
salin
sodium
chlorid
may
use
conjunct
therapi
reliev
discomfort
eye
dilut
allergen
inflammatori
mediat
releas
allerg
respons
lubric
eye
drop
contain
lubric
carmellos
may
use
often
requir
insuffici
lubric
achiev
eye
drop
gel
ointment
appli
sleep
may
consid
prevent
allerg
conjunct
achiev
allergen
avoid
caus
allergen
known
patient
take
necessari
measur
avoid
minim
exposur
practic
measur
may
includ
limit
time
outdoor
high
pollen
count
keep
window
door
shut
use
air
filter
air
condit
unit
undertak
strict
clean
routin
reduc
anim
dander
dust
mite
specif
allergen
identifi
physician
may
refer
patient
investig
skin
prick
test
commun
pharmacist
abl
reach
differenti
diagnosi
come
allergi
condit
present
similarli
event
clear
differenti
diagnosi
reach
patient
refer
either
medic
practition
optometrist
assess
nasal
allergi
obstruct
rhinorrhea
one
nostril
may
indic
presenc
foreign
object
nose
particularli
consid
pediatr
patient
rhiniti
symptom
persist
despit
overthecount
treatment
assess
possibl
prescript
therapi
medic
practition
rhiniti
associ
pain
suspect
result
medic
use
either
prolong
use
topic
decongest
drug
known
caus
rhiniti
medicamentosa
due
associ
poorli
manag
allerg
rhiniti
worsen
asthma
patient
comorbid
asthma
control
assess
pharmacist
eg
frequenc
reliev
use
refer
worsen
asthma
symptom
occur
case
ocular
allergi
addit
nonspecif
referr
point
overthecount
treatment
failur
specif
referr
point
includ
chang
vision
foreign
bodi
present
eye
pain
photophobia
patient
refer
eye
condit
includ
allerg
condit
may
result
scale
chang
eye
lid
surround
tissu
condit
beyond
scope
commun
pharmaci
practic
also
review
medic
practition
similar
mani
common
minor
ailment
commun
pharmaci
among
primari
healthcar
provid
often
first
port
call
peopl
experienc
allergi
sign
symptom
upper
respiratori
tract
infect
pharmacist
uniqu
opportun
due
access
expertis
medicin
make
differenti
diagnosi
educ
patient
manag
common
condit
provid
appropri
therapi
advic
consum
expect
overthecount
product
manag
common
cold
associ
symptom
may
high
pharmacist
educ
patient
expect
effect
overthecount
medicin
includ
complementari
altern
medicin
comment
limit
evid
support
use
patient
remind
cure
common
cold
influenza
antibiot
play
role
manag
infect
viral
origin
particular
import
jurisdict
antibiot
avail
overthecount
without
physician
prescript
consum
demand
may
high
alway
pharmacist
promot
safe
judici
appropri
use
medicin
consum
may
misconcept
common
cold
influenza
includ
need
seek
medic
attent
common
cold
case
pharmacist
dispel
myth
surround
common
infect
act
triag
truli
need
referr
medic
assess
base
present
symptom
therebi
reduc
burden
health
system
ailment
easili
manag
scope
commun
pharmaci
local
law
permit
pharmacist
also
offer
administ
vaccin
season
influenza
infecti
diseas
patient
elig
literatur
demonstr
peopl
live
allerg
rhiniti
frequent
speak
healthcar
profession
condit
instead
make
correct
selfdiagnosi
selfselect
overthecount
treatment
readili
avail
sever
reason
propos
includ
selfpercept
allerg
rhiniti
rel
less
sever
asthma
given
two
frequent
comorbid
given
consum
may
discuss
allerg
rhiniti
physician
pharmacist
take
opportun
engag
consum
request
medicin
antihistamin
intranas
corticosteroid
elicit
histori
make
differenti
diagnosi
pharmacist
assist
patient
optim
therapi
explain
correct
use
devic
educ
patient
allerg
rhiniti
exampl
emphas
benefit
comorbid
asthma
allerg
rhiniti
manag
appropri
final
pharmacist
identifi
patient
requir
referr
anoth
healthcar
provid
medic
practition
optometrist
